This is a working overview of incretin, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-07-19. Anything still debated is marked as such rather than presented as settled.
Retatrutide is an investigational peptide developed by a pharmaceutical company as a multi-receptor agonist for treating obesity and type 2 diabetes. The compound emerged from research into gut-hormone analogues that act on several receptors simultaneously rather than on a single target. Early preclinical work examined how combined activity at three distinct receptors might produce greater metabolic effects than single-receptor compounds. Published phase 2 results have described substantial reductions in body weight among participants, although the compound remains unapproved in most jurisdictions as of the mid-2020s.
Pharmacologically, retatrutide acts as a triple agonist at the glucagon-like peptide-1 receptor, the glucose-dependent insulinotropic polypeptide receptor, and the glucagon receptor. Activation of the first two receptors is associated with improved insulin secretion and reduced appetite. The glucagon receptor component is thought to increase energy expenditure, a mechanism that distinguishes this molecule from dual-agonist compounds. Researchers continue to investigate how the three activities interact and whether the combined profile offers advantages that justify additional clinical testing.
Several questions about the compound remain unresolved. The durability of weight reduction after treatment stops, the frequency of gastrointestinal side effects, and the long-term cardiovascular profile are topics of ongoing study. Regulatory submissions and phase 3 trial outcomes have not been fully reported in the public literature. Because most available data come from controlled trials rather than general-population use, conclusions about effectiveness outside study settings are provisional. The distinction between established findings and open questions matters when interpreting early coverage of the drug.
Mechanistic proposals link each receptor to a different physiological role. Activation of the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors is associated with reduced appetite, slower gastric emptying, and glucose-dependent insulin release. Glucagon receptor signaling, by contrast, is associated with increased energy expenditure and altered lipid handling, though it can also raise blood glucose. The design intent is to balance these contributions so that weight reduction is enhanced without unacceptable glycemic trade-offs. How well that balance holds across individuals is not fully resolved.
Published information places retatrutide in clinical development rather than on the market as an approved therapy. Early-stage and mid-stage trials have examined tolerability and changes in body weight, and larger studies continue to report results over time. Open questions include the durability of effects after treatment stops, the composition of weight lost, and cardiovascular outcomes over long periods. Statements about definitive benefit should therefore be treated as provisional. Regulatory status varies by jurisdiction and changes as applications are reviewed.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Contains non-natural residues |
| Receptor targets | GLP-1, GIP, glucagon | Triple agonist profile |
| Route of administration | Subcutaneous injection | In clinical trial settings |
| Development status | Investigational | Not approved in major markets |
| Approximate molecular mass | About 4.7 kDa | Peptide-scale molecule |
供应环节涉及来源核实与文件审核两类工作。分析证书、批次记录以及第三方检测报告构成常见的可追溯材料。来源不清的样品很难确认身份与纯度，因此核实步骤在实际操作中具有明确意义。缺少方法细节的报告通常无法复核。
多肽类化合物的表征通常依赖色谱与质谱联用技术。反相高效液相色谱用于评估纯度与有关物质，质谱用于确认分子量，肽图分析通过酶解碎片比对验证一级结构。这些手段组合使用，可以把目标产物与降解产物或类似物区分开来。单一方法往往不足以完成完整确认。
稳定性研究一般关注脱酰胺、氧化与聚集三类降解路径。脱酰胺多发生在天冬酰胺残基上，氧化常涉及甲硫氨酸与色氨酸，聚集则与浓度、温度以及容器界面接触有关。强制降解实验用于识别分子中较敏感的位点。这些结果会直接影响储存条件的设定与有效期的判断。
Development has progressed through early- and mid-stage human studies in adults with obesity and with type 2 diabetes. Published phase 2 data reported reductions in body weight and improvements in glycemic markers over the treatment period. No regulatory agency has approved the compound for any indication, and it remains available only within controlled research settings. Whether benefits observed in trials translate into durable outcomes after treatment stops is not yet established.
Retatrutide is an investigational synthetic peptide that acts as an agonist at three distinct G protein-coupled receptors. It combines activity at the glucagon-like peptide-1 receptor, the glucose-dependent insulinotropic polypeptide receptor, and the glucagon receptor within a single molecule. This multi-receptor profile distinguishes it from earlier incretin-based compounds that engage one or two of these pathways. Researchers designed the molecule to test whether simultaneous activation produces greater metabolic effects than single or dual agonism alone.
Clinical development has progressed through phase 2 trials in adults with obesity and type 2 diabetes, with phase 3 programs reported as ongoing. Reported outcomes include reductions in body weight and improvements in glycemic measures over defined treatment periods. Whether these effects translate into durable benefits after treatment ends remains an open question. Long-term safety data across broad populations are not yet complete, and regulatory decisions have not been announced.
Retatrutide is an investigational synthetic peptide engineered to activate three distinct hormone receptors within a single molecule. It targets the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor simultaneously. This triagonist design distinguishes it from earlier incretin-based compounds that act on one or two of these pathways. Structural modifications relative to native gut hormones extend its residence time in circulation. The molecule remains under clinical evaluation and is not approved for any indication.
Receptor activation produces downstream effects that differ by tissue. GLP-1 receptor signaling influences appetite regulation and insulin secretion in a glucose-dependent manner. GIP receptor activity contributes to metabolic handling of nutrients and may modulate adipose tissue. Glucagon receptor engagement raises energy expenditure and promotes hepatic lipid turnover, though the balance among these actions in humans is still being characterized. Preclinical models showed reductions in body weight and improved glycemic markers.
Scott, who said he received a phone call from Secretary of State Marco Rubio early Saturday morning, also praised Venezuelan opposition leader María Corina Machado for her role in the events. Gimenez stated that Trump had also "turned his eye" toward Cuba, noting that "the Cuban regime is at the weakest point it's been in a very, very long time." Governor Ron DeSantis supported the operation and said that the Attorney General of Florida was “looking very seriously” at the possibility of filing state charges against Maduro aside from the federal indictment, accusing him of bring drugs and violent criminals to Florida. Democratic senator Brian Schatz, a member of the Senate Foreign Relations Committee, warned against any US military involvement in Venezuela, saying that the United States has "no vital national interests in Venezuela to justify war". Democratic senator Ruben Gallego said "this war is illegal". Democratic senator Tim Kaine condemned the actions and called on Congress to support his resolution to block the use of the armed forces against Venezuela unless authorized by Congress. Senator Bernie Sanders also condemned the strikes, citing a risk of global instability and accusing Trump of bypassing Congress to get the country into war. Former vice president Kamala Harris criticized the strikes. The mayor of New York City, Zohran Mamdani, said he called Trump earlier that day to express his opposition to the strikes.
=== Structural classification === Beyond chemical composition, cages are also classified based on their structural characteristics. Shape-persistent cages maintain fixed conformations due to their rigid building blocks and strong covalent bonds, providing stable and predictable cavity environments. In contrast, flexible cages exhibit dynamic structures that can adapt to guest molecules through conformational changes, allowing for responsive host-guest interactions. This flexibility can be advantageous in applications requiring adaptive binding, such as selective molecular capture under varying conditions. Some systems even form hierarchical assemblies, creating cage-of-cage structures with complex internal architectures that can provide multiple distinct environments for guest molecules or cascade reactions.
== Mechanism of action == Duchenne muscular dystrophy is caused when a mutation in the DMD gene changes the DMD mRNA so that it no longer codes for functional dystrophin protein, usually due to a nonsense mutation that introduces a premature stop codon into the mRNA. If an exon with an appropriate number of bases lies near the mutation, by removing the defective exon the downstream reading frame can be corrected and production of partially functional dystrophin can be restored. This is the general strategy used for designing exon-skipping oligos for DMD; as there are 79 exons transcribed in the longest splice form of the dystrophin transcript, many different oligos are needed to address the range of mutations present in the population of people with DMD. Eteplirsen is a morpholino antisense oligomer which triggers excision of exon 51 during pre-mRNA splicing of the dystrophin RNA transcript. Skipping exon 51 changes the downstream reading frame of dystrophin; giving eteplirsen to a healthy person would result in production of dystrophin mRNA which would not code for functional dystrophin protein but, for DMD patients with particular nonsense mutations, giving eteplirsen can restore the reading frame of the dystrophin mRNA and result in production of functional (although modified by having an internal deletion consisting of both the patient's original defect, as well as the therapeutically skipped exon) dystrophin. Eteplirsen is given by intravenous infusion for systemic treatment of DMD.
In North Africa, the Wehrmacht shipped in fresh fruit from Italy and Greece to supplement its troops' rations, even during the Great Famine in Greece. The Imperial Japanese Army and Navy received rather basic rations, usually consisting of rice with barley, meat or fish, pickled or fresh vegetables, umeboshi, soy sauce, miso or bean paste, and green tea. The rations were intended to be eaten with other foraged food. Japanese soldiers were also issued emergency rations. The standard emergency ration, intended to last for five days, included a small sack of rice, package of compact food, package of hardtack, one-half pound (230 g) of hard candy, can of tea, and vitamin pills. Japanese soldiers also hunted dogs, goats, and other small animals to add to their emergency rations. In the Burma campaign, two types of emergency rations were used, "A" rations intended for three days consisting of 19 ounces (540 g) of rice and a small can of beef and vegetables, and "B" rations intended for one day consisting of three bags of hard biscuits. They were meant to be eaten only upon orders from a commanding officer when the unit was separated from its supply column. Japanese soldiers were often undersupplied. Japanese commanders had a cavalier attitude to food supplies for their troops and supply lines were often not protected. As a result, about 60% of Japanese military deaths during the war were due to starvation.
Sources: en.wikipedia.org
=== Toxicity === A 2022 study concluded that SAMe could be toxic. Jean-Michel Fustin of Manchester University said that the researchers found that excess SAMe breaks down into adenine and methylthioadenosine in the body, both producing the paradoxical effect of inhibiting methylation. This was found in laboratory mice, causing harm to health, and in in vitro tests on human cells.
Krishna Kamal Tanti is a Bharatiya Janata Party politician from the Indian state of Assam. He has been elected in Assam Legislative Assembly election in 2021 from Rangapara. He is also a member of the advisory board on the eradication of Child Labour.
In molecular biology, a selenoprotein is any protein that includes a selenocysteine (Sec, U, Se-Cys) amino acid residue. Among functionally characterized selenoproteins are five glutathione peroxidases (GPX) and three thioredoxin reductases, (TrxR/TXNRD) which both contain only one Sec. Selenoprotein P is the most common selenoprotein found in the plasma. It is unusual because in humans it contains 10 Sec residues, which are split into two domains, a longer N-terminal domain that contains 1 Sec, and a shorter C-terminal domain that contains 9 Sec. The longer N-terminal domain is likely an enzymatic domain, and the shorter C-terminal domain is likely a means of safely transporting the very reactive selenium atom throughout the body.
In addition to psychedelics being defined as controlled substances at the federal level, individual U.S. states, such as Alabama, may also make psychedelics controlled substances within their jurisdictions. Conversely, state-level and lower jurisdictions may alternatively legalize or decriminalize psychedelics, for instance Colorado and Oregon and individual cities like San Francisco. This can result in legal conflict and ambiguity at different levels of government, for example a given drug being illegal at the federal level but legal at the state level.
=== Vibrational (infrared and Raman) spectroscopy of metallocenes === Infrared and Raman spectroscopies have proved to be important in the analysis of cyclic polyenyl metal sandwich species, with particular use in elucidating covalent or ionic M–ring bonds and distinguishing between central and coordinated rings. Some typical spectral bands and assignments of iron group metallocenes are shown in the following table:
Sources: en.wikipedia.org
== Pharmacology == Chlorpromazine is classified as a low-potency typical antipsychotic. Low-potency antipsychotics have more anticholinergic side effects, such as dry mouth, sedation, and constipation, and lower rates of extrapyramidal side effects, while high-potency antipsychotics (such as haloperidol) have the reverse profile.
=== Spider and other silks === Spider silk, particularly the dragline silk of orb-weaving spiders, is both very strong and highly extensible, which places it among the toughest natural fibres known. The principal constraint is supply. Spiders are territorial and cannibalistic and cannot be farmed as silkworms are, so natural spider silk remains scarce. Instead, spider-silk proteins are produced by genetic engineering and expressed in bacteria, yeast or other hosts. Silks from wild silkmoths such as Antheraea species, and from other insects, have also been examined; they differ in amino acid sequence and in how they interact with cells.
Taco Time (stylized as TacoTime) is an American fast-food restaurant chain specializing in Mexican-American food. The chain has over 226 locations in the United States and 74 locations in Western Canada. It was founded in Eugene, Oregon, in 1960 by Ron Fraedrick.
== Pharmacology == It is a derivative of isonipecotic acid, like pethidine, and is metabolized in part to norpethidine. Its potency range is due to method of ingestion. figure 20–80 times as potent as pethidine as an analgesic. The greatly increased potency essentially eliminates the toxic effects of norpethidine accumulation which are seen when pethidine is administered in high doses or for long periods of time.
linking to primary rather than secondary sources and prioritizing stable sites avoiding links that point to resources on researchers' personal pages using clean URLs or otherwise employing URL normalization or URL canonicalization using permalinks and persistent identifiers such as ARKs, DOIs, Handle System references, PURLs, or content addressing avoiding linking to documents other than web pages avoiding deep linking linking to web archives such as the Internet Archive, WebCite, archive.today, Perma.cc, Amber, or Arweave Strategies pertaining to the protection of existing links include:
Sources: en.wikipedia.org
It is designed as a triple agonist acting on the GLP-1, GIP, and glucagon receptors. This combination is intended to influence appetite, insulin secretion, and energy expenditure. Single-receptor and dual-receptor compounds act on a narrower set of targets.
No. It remains investigational, and phase 3 results have not been fully published or reviewed by regulators. Official approval status should be confirmed through regulatory agencies rather than secondary sources.
The added glucagon receptor activity is the main difference in its mechanism. Whether that addition produces meaningful benefits in clinical outcomes is still being studied. Comparisons between compounds rest largely on indirect rather than head-to-head trial data.
It is described as a single molecule that acts at three receptors: the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor. This triple activity distinguishes it from agents that target one or two of these pathways.